glp-1 usage by state West Virginia has been ranked as the with the highest drug rate in the United States. , Nearly one in four West Virginians was on a GLP-1 drug as of 2024, the highest rate in the State Medicaid Programs Increasingly Opting

Injectable Wegovy has demonstrated approximately 15% weight loss in clinical trials, while Eli Lillys Zepbounda dual GIP/GLP-1 agonistshows approximately 21% weight loss at its highest dose

Managing Side Effects: Start with low doses and increase gradually

Rather, clinicians prefer a low starting dose, typically 2 to 4 mg per week

What should I do if I experience hot flushes whilst taking Mounjaro

Additionally, the appetite suppression that contributes to weight loss can inadvertently lead to reduced electrolyte intake if patients significantly decrease their food and beverage consumption

What the current research actually says Honesty matters more than enthusiasm when evaluating an untested combination